Hospital Britanico Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
1996
NCT00367562
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Hospital Britanico | HOSPITAL BRITANICO DE BUENOS AIRES

Active Ingredients

Drugs in Phase 4 Trials (3)

enalapril (vasotec) (1 trial)

methylprednisolone (medrol) (1 trial)

valsartan (diovan) (1 trial)

Drugs in Phase 3 Trials (2)

bacillus clausii (1 trial)

trimebutine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glomerulonephritis, IGA (Phase 4)

Irritable Bowel Syndrome (Phase 3)

Kidney Diseases (Phase 4)

Proteinuria (Phase 4)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 5